SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-202576
Filing Date
2022-07-27
Accepted
2022-07-27 06:13:03
Documents
13
Period of Report
2022-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d341135d8k.htm   iXBRL 8-K 24740
2 EX-99.1 d341135dex991.htm EX-99.1 11382
  Complete submission text file 0001193125-22-202576.txt   166349

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idya-20220726.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20220726_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20220726_pre.xml EX-101.PRE 11713
7 EXTRACTED XBRL INSTANCE DOCUMENT d341135d8k_htm.xml XML 3482
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 221108749
SIC: 2834 Pharmaceutical Preparations